SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-023264
Filing Date
2023-05-19
Accepted
2023-05-19 16:26:44
Documents
16
Period of Report
2023-05-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K celu-20230516.htm   iXBRL 8-K 75472
2 EX-10.1 celu-ex10_1.htm EX-10.1 357939
3 EX-10.2 celu-ex10_2.htm EX-10.2 205603
4 EX-10.3 celu-ex10_3.htm EX-10.3 335858
  Complete submission text file 0000950170-23-023264.txt   1241970

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celu-20230516_def.xml EX-101.DEF 14174
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celu-20230516_lab.xml EX-101.LAB 17766
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celu-20230516_pre.xml EX-101.PRE 14184
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celu-20230516.xsd EX-101.SCH 3461
10 EXTRACTED XBRL INSTANCE DOCUMENT celu-20230516_htm.xml XML 6500
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 23940522
SIC: 2834 Pharmaceutical Preparations